Beyond Side Effects: The Role of Dissociation in Esketamine Therapy for Treatment-Resistant Depression

Dissociation is a common acute effect of esketamine and has been hypothesized to influence antidepressant outcomes in treatment-resistant depression. However, its clinical relevance, particularly among patients with trauma-related comorbidities, remains uncertain. We conducted a retrospective chart review of 51 adults with treatment-resistant depression treated with intranasal esketamine in a specialized outpatient esketamine unit at Lev Hasharon Mental Health Center, Israel (2021–2025), where treatment was delivered according to a structured induction and maintenance protocol. Baseline trait dissociation was assessed using the Dissociative Experiences Scale-II (DES-II), and session-related state dissociation was measured weekly with the Peritraumatic Dissociative Experiences Questionnaire (PDEQ). Depressive severity was monitored via QIDS-SR16 at and throughout treatment. Associations between dissociation and depressive outcomes were examined using correlation and linear mixed-effects models. Higher trait dissociation was associated with greater depressive severity (r = .28, p = .03) and was elevated among patients with trauma-related comorbidities. Despite this, dissociation did not affect the pace or magnitude of improvement in depressive symptoms over weeks of treatment. Trait and state dissociation were moderately correlated (r = .310, p = .038), indicating that individuals with higher trait dissociative tendencies experienced stronger in-session dissociation. While session-level dissociation showed a trend-level association with higher depressive scores at the following visit (p ≈ .06), it did not diminish antidepressant efficacy. Elevated trait dissociation and trauma-related psychopathology amplify initial depressive burden but do not hinder esketamine’s effect. The transient link between in-session dissociation and short-term mood worsening echoes patterns seen in psychedelic-assisted therapy and highlights the value of brief, post-session integration support. Dissociation appears to be an epiphenomenon rather than a determinant of treatment success.

Authors

Institutions

Publication Details

Journal
Journal of Trauma & Dissociation
Published
2026-11-18
DOI
https://doi.org/10.1080/15299732.2026.2763363
Primary Topic
Treatment of Major Depression
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond Side Effects: The Role of Dissociation in Esketamine Therapy for Treatment-Resistant Depression

Kfir Feffer, Esther Bloemhof‐Bris, Yaara Ben Ari, Li Pardo-Aviv
4 links
Journal of Trauma & Dissociation
Treatment of Major Depression
article

Beyond Side Effects: The Role of Dissociation in Esketamine Therapy for Treatment-Resistant Depression

Kfir Feffer, Esther Bloemhof‐Bris, Yaara Ben Ari, Li Pardo-Aviv
article en

Abstract

Dissociation is a common acute effect of esketamine and has been hypothesized to influence antidepressant outcomes in treatment-resistant depression. However, its clinical relevance, particularly among patients with trauma-related comorbidities, remains uncertain. We conducted a retrospective chart review of 51 adults with treatment-resistant depression treated with intranasal esketamine in a specialized outpatient esketamine unit at Lev Hasharon Mental Health Center, Israel (2021–2025), where treatment was delivered according to a structured induction and maintenance protocol. Baseline trait dissociation was assessed using the Dissociative Experiences Scale-II (DES-II), and session-related state dissociation was measured weekly with the Peritraumatic Dissociative Experiences Questionnaire (PDEQ). Depressive severity was monitored via QIDS-SR16 at and throughout treatment. Associations between dissociation and depressive outcomes were examined using correlation and linear mixed-effects models. Higher trait dissociation was associated with greater depressive severity (r = .28, p = .03) and was elevated among patients with trauma-related comorbidities. Despite this, dissociation did not affect the pace or magnitude of improvement in depressive symptoms over weeks of treatment. Trait and state dissociation were moderately correlated (r = .310, p = .038), indicating that individuals with higher trait dissociative tendencies experienced stronger in-session dissociation. While session-level dissociation showed a trend-level association with higher depressive scores at the following visit (p ≈ .06), it did not diminish antidepressant efficacy. Elevated trait dissociation and trauma-related psychopathology amplify initial depressive burden but do not hinder esketamine’s effect. The transient link between in-session dissociation and short-term mood worsening echoes patterns seen in psychedelic-assisted therapy and highlights the value of brief, post-session integration support. Dissociation appears to be an epiphenomenon rather than a determinant of treatment success.

Journal of Trauma & Dissociation
Reichman University (IL), Tel Aviv University (IL), Lev Hasharon Hospital (IL)
Good health and well-being
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon